Beremagene geperpavec (B-VEC)
the first topical gene therapy for dystrophic epidermolysis bullosa
Wang E, Dhillon J, Sanabria B, Pathak GN, Rao B, Murrell DF
Archives of Dermatological ResearchIn the feed 9 Oct 2026, published online 9 Oct 2026
Topics: Genetic skin disease
Abstract
The publisher hasn’t shared an abstract for this paper. Their page has the full paper.
DOI 10.1007/s00403-026-04864-5 · Not in PubMed: details from Crossref